Literature DB >> 26894912

Targeted overexpression of tumor necrosis factor-α increases cyclin-dependent kinase 5 activity and TRPV1-dependent Ca2+ influx in trigeminal neurons.

Pablo Rozas1, Pablo Lazcano, Ricardo Piña, Andrew Cho, Anita Terse, Maria Pertusa, Rodolfo Madrid, Christian Gonzalez-Billault, Ashok B Kulkarni, Elias Utreras.   

Abstract

We reported earlier that TNF-α, a proinflammatory cytokine implicated in many inflammatory disorders causing orofacial pain, increases the activity of Cdk5, a key kinase involved in brain development and function and recently found to be involved in pain signaling. To investigate a potential mechanism underlying inflammatory pain in trigeminal ganglia (TGs), we engineered a transgenic mouse model (TNF) that can conditionally overexpresses TNF-α upon genomic recombination by Cre recombinase. TNF mice were bred with Nav1.8-Cre mouse line that expresses the Cre recombinase in sensory neurons to obtain TNF-α:Nav1.8-Cre (TNF-α cTg) mice. Although TNF-α cTg mice appeared normal without any gross phenotype, they displayed a significant increase in TNF-α levels after activation of NFκB signaling in the TG. IL-6 and MCP-1 levels were also increased along with intense immunostaining for Iba1 and GFAP in TG, indicating the presence of infiltrating macrophages and the activation of satellite glial cells. TNF-α cTg mice displayed increased trigeminal Cdk5 activity, and this increase was associated with elevated levels of phospho-T407-TRPV1 and capsaicin-evocated Ca influx in cultured trigeminal neurons. Remarkably, this effect was prevented by roscovitine, an inhibitor of Cdk5, which suggests that TNF-α overexpression induced sensitization of the TRPV1 channel. Furthermore, TNF-α cTg mice displayed more aversive behavior to noxious thermal stimulation (45°C) of the face in an operant pain assessment device as compared with control mice. In summary, TNF-α overexpression in the sensory neurons of TNF-α cTg mice results in inflammatory sensitization and increased Cdk5 activity; therefore, this mouse model would be valuable for investigating the mechanism of TNF-α involved in orofacial pain.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26894912      PMCID: PMC4868804          DOI: 10.1097/j.pain.0000000000000527

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  70 in total

1.  A system for applying rapid warming or cooling stimuli to cells during patch clamp recording or ion imaging.

Authors:  G Reid; B Amuzescu; E Zech; M L Flonta
Journal:  J Neurosci Methods       Date:  2001-10-15       Impact factor: 2.390

2.  Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1.

Authors:  Tej K Pareek; Jason Keller; Sashi Kesavapany; Nitin Agarwal; Rohini Kuner; Harish C Pant; Michael J Iadarola; Roscoe O Brady; Ashok B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-28       Impact factor: 11.205

3.  Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling.

Authors:  Satoru Takahashi; Toshio Ohshima; Andrew Cho; Taduru Sreenath; Michael J Iadarola; Harish C Pant; Yong Kim; Angus C Nairn; Roscoe O Brady; Paul Greengard; Ashok B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

4.  Tumor necrosis factor alpha enhances the sensitivity of rat trigeminal neurons to capsaicin.

Authors:  A A Khan; A Diogenes; N A Jeske; M A Henry; A Akopian; K M Hargreaves
Journal:  Neuroscience       Date:  2008-06-05       Impact factor: 3.590

Review 5.  Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia.

Authors:  Claudia Sommer; Michaela Kress
Journal:  Neurosci Lett       Date:  2004-05-06       Impact factor: 3.046

Review 6.  Cdk5 activity in the brain - multiple paths of regulation.

Authors:  Kavita Shah; Debomoy K Lahiri
Journal:  J Cell Sci       Date:  2014-06-01       Impact factor: 5.285

Review 7.  Tumor necrosis factor signaling.

Authors:  H Wajant; K Pfizenmaier; P Scheurich
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

8.  Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia.

Authors:  Michaela Prochazkova; Anita Terse; Niranjana D Amin; Bradford Hall; Elias Utreras; Harish C Pant; Ashok B Kulkarni
Journal:  Mol Pain       Date:  2013-12-21       Impact factor: 3.395

9.  TNFα levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine.

Authors:  Alessia Franceschini; Sandra Vilotti; Michel D Ferrari; Arn M J M van den Maagdenberg; Andrea Nistri; Elsa Fabbretti
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

10.  ERK MAP kinase activation in spinal cord regulates phosphorylation of Cdk5 at serine 159 and contributes to peripheral inflammation induced pain/hypersensitivity.

Authors:  Xiaoqin Zhang; Honghai Zhang; Haijun Shao; Qingsheng Xue; Buwei Yu
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

View more
  18 in total

1.  TNF-α/TNFR1 Signaling is Required for the Full Expression of Acute and Chronic Itch in Mice via Peripheral and Central Mechanisms.

Authors:  Xiuhua Miao; Ya Huang; Teng-Teng Liu; Ran Guo; Bing Wang; Xue-Long Wang; Li-Hua Chen; Yan Zhou; Ru-Rong Ji; Tong Liu
Journal:  Neurosci Bull       Date:  2017-04-01       Impact factor: 5.203

Review 2.  Sustained sensitizing effects of tumor necrosis factor alpha on sensory nerves in lung and airways.

Authors:  Ruei-Lung Lin; Qihai Gu; Mehdi Khosravi; Lu-Yuan Lee
Journal:  Pulm Pharmacol Ther       Date:  2017-06-03       Impact factor: 3.410

3.  Targeted TNF-α Overexpression Drives Salivary Gland Inflammation.

Authors:  A Limaye; B E Hall; L Zhang; A Cho; M Prochazkova; C Zheng; M Walker; F Adewusi; P D Burbelo; Z J Sun; I S Ambudkar; J C Dolan; B L Schmidt; A B Kulkarni
Journal:  J Dent Res       Date:  2019-04-08       Impact factor: 6.116

4.  Protocols for Characterization of Cdk5 Kinase Activity.

Authors:  Anita Terse; Niranjana Amin; Bradford Hall; Manju Bhaskar; Binukumar B K; Elias Utreras; Tej K Pareek; Harish Pant; Ashok B Kulkarni
Journal:  Curr Protoc       Date:  2021-10

5.  Hydroxylated Fullerene: A Stellar Nanomedicine to Treat Lumbar Radiculopathy via Antagonizing TNF-α-Induced Ion Channel Activation, Calcium Signaling, and Neuropeptide Production.

Authors:  Li Xiao; Kwangseok Hong; Charles Roberson; Mengmeng Ding; Andrew Fernandez; Francis Shen; Li Jin; Swapnil Sonkusare; Xudong Li
Journal:  ACS Biomater Sci Eng       Date:  2017-12-07

Review 6.  Physiology and Pathophysiology of Itch.

Authors:  Ferda Cevikbas; Ethan A Lerner
Journal:  Physiol Rev       Date:  2019-12-23       Impact factor: 37.312

7.  Cyclin-dependent kinase 5 modulates the P2X2a receptor channel gating through phosphorylation of C-terminal threonine 372.

Authors:  Claudio Coddou; Rodrigo Sandoval; Patricio Castro; Pablo Lazcano; Maria José Hevia; Milos Rokic; Bradford Hall; Anita Terse; Christian Gonzalez-Billault; Ashok B Kulkarni; Stanko S Stojilkovic; Elias Utreras
Journal:  Pain       Date:  2017-11       Impact factor: 7.926

8.  Intrathecal Resiniferatoxin Modulates TRPV1 in DRG Neurons and Reduces TNF-Induced Pain-Related Behavior.

Authors:  M Leo; M Schulte; L-I Schmitt; M Schäfers; C Kleinschnitz; T Hagenacker
Journal:  Mediators Inflamm       Date:  2017-08-02       Impact factor: 4.711

9.  TNF-α Increases Production of Reactive Oxygen Species through Cdk5 Activation in Nociceptive Neurons.

Authors:  Rodrigo Sandoval; Pablo Lazcano; Franco Ferrari; Nicolás Pinto-Pardo; Christian González-Billault; Elías Utreras
Journal:  Front Physiol       Date:  2018-02-06       Impact factor: 4.566

Review 10.  Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain.

Authors:  Muhammad Saad Yousuf; Stephanie I Shiers; James J Sahn; Theodore J Price
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.